Suillus luteus methanolic extract inhibits cell growth and proliferation of a colon cancer cell line

Food Research International

Volumn 53, Issue 1, 2013, Pages 476-481

  Santos, Tiago dos ^a   Tavares, Catarina ^a   Sousa, Diana ^a   Vaz, Josiana A ^a,b   Calhelha, Ricardo C ^b,c   Martins, Anabela ^b   Almeida, Gabriela M ^a   Ferreira, Isabel C F R ^b   Vasconcelos, M Helena ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Methanolic extract; Suillus luteus; Tumor cell growth; Tumor cell proliferation

Indexed keywords

COLON CANCER CELLS; EDIBLE MUSHROOM; GROWTH INHIBITION; HUMAN TUMOR CELL LINES; METHANOLIC EXTRACTS; NON SMALL CELL LUNG CANCER; SUILLUS LUTEUS; TUMOR CELLS;

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; GROWTH KINETICS;

CELL GROWTH;

EID: 84879479075     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2013.05.037     Document Type: Article

References (29)

1. Abreu R.M.V., Ferreira I.C.F.R., Calhelha R.C., Lima R.T., Vasconcelos M.H., Adega F., et al. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: In vitro evaluation, cell cycle analysis and QSAR studies. European Journal of Medicinal Chemistry 2011, 46:5800-5806.
2. Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. Journal of Biological Chemistry 1996, 22:12695-12698.
3. Campomenosi P., Monti P., Paola, Aprile A., Abbondandolo A., Frebourg T., et al. Oncogene 2001, 20:3573-3579.
4. Courtecuisse R., Duhem B. Guía de los hongos de la Peninsula Ibérica, Europa y Norte de África 2005, Ediciones Omega, Barcelona.
5. DeYoung M.P., Ellisen L.W. p63 and p73 in human cancer: Defining the network. Oncogene 2007, 26:5169-5183.
6. Falck J., Lukas C., Protopopova M., Lukas J., Selivanova G., Bartek J. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 2001, 20:5503-5510.
7. Ferreira I.C.F.R., Vaz J.A., Vasconcelos M.A., Martins A. Compounds from wild mushrooms with antitumour potential. Anti-Cancer Agents in Medicinal Chemistry 2010, 10:424-436.
8. Kalač P. Chemical composition and nutritional value of European species of wild growing mushrooms: A review. Food Chemistry 2009, 113:9-16.
9. Lamb H.M., Hardwick J.M. Unlatched BAX pairs for death. Cell 2013, 152:383-384.
10. León F., Brouard I., Torres F., Quintana J., Rivera A., Estévez F., et al. A new ceramide from Suillus luteus and its cytotoxic activity against human melanoma cells. Chemical Biodiversity 2008, 5:120-125.
11. Li J.W.-H., Vederas J.C. Drug discovery and natural products: End of an era or an endless frontier. Science 2009, 325:161-165.
12. Luk S.-U., Lee T.K.-W., Liu J., Lee D.T.-W., Chiu Y.-T., Ma S., et al. Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One 2011, 6:e19804.
13. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute 1991, 83:757-766.
14. Moradali M.-F., Mostafavi H., Ghods S., Hedjaroude G.-A. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology 2007, 7:701-724.
15. Müller M., Schleithoff E.S., Stremmel W., Melino G., Krammerd P.H., Schilling T. One, two, three - p53, p63, p73 and chemosensitivity. Drug Resistance Updates 2006, 9:288-306.
16. O'Reilly L.A., Huang D.C.S., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO Journal 1996, 15:6979-6990.
17. O'Connor P.M., Jackman J., Bae I., Myers T.G., Fan S., Mutoh M., et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Research 1997, 57:4285-4300.
18. Palmeira A., Paiva A., Sousa E., Seca H., Almeida G.M., Lima R.T., et al. Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone. Chemical Biology & Drug Design 2010, 76:43-58.
19. Poucheret P., Fons F., Rapior S. Biological and pharmacological activity of higher fungi: 20-Year retrospective analysis. Cryptogamie Mycologie 2006, 27:311-333.
20. Queiroz M.J., Calhelha R.C., Vale-Silva L.A., Pinto E., Lima R.T., Vasconcelos M.H. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling: Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle. European Journal of Medicinal Chemistry 2010, 45:5628-5634.
21. Reis F.S., Heleno S.A., Barros L., Sousa M.J., Martins A., Santos-Buelga C., et al. Toward the antioxidant and chemical characterization of mycorrhizal mushrooms from Northeast Portugal. Journal of Food Science 2011, 76:824-830.
22. Skehan P., Storeng R., Scudiero D., Monks A., MacMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 1990, 82:1107-1112.
23. Strano S.S., Dell'Orso S., Di Agostino S., Fontemaggi G., Sacchi A., Blandino G. Mutant p53: An oncogenic transcription factor. Oncogene 2007, 26:2212-2219.
24. Tomasi S., Lohézic-Le Dévéhat F., Sauleau P., Bézivin C., Boustie J. Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie 2004, 59:290-293.
25. Vasconcelos M.H., Beleza S.S., Quirk C., Maia L.F., Sambade C., Guimarães J.E. Limited synergistic effect of antisense oligonucleotides against bcr-abl and transferrin receptor mRNA in leukemic cells in culture. Cancer Letters 2000, 152:135-143.
26. Vaz J.A., Almeida G.M., Ferreira I.C.F.R., Martins A., Vasconcelos M.H. Clitocybe alexandri extract induces cell cycle arrest and apoptosis in a lung cancer cell line: Identification of phenolic acids with cytotoxic potential. Food Chemistry 2012, 132:482-486.
27. Vaz J.A., Ferreira I.C.F.R., Tavares C., Almeida G.M., Martins A., Vasconcelos M.H. Suillus collinitus methanolic extract increases p53 expression and causes cell cycle arrest and apoptosis in a breast cancer cell line. Food Chemistry 2012, 135:596-602.
28. Vaz J.A., Heleno S.A., Martins A., Almeida G.M., Vasconcelos M.H., Ferreira I.C.F.R. Wild mushrooms Clitocybe alexandri and Lepista inversa: In vitro antioxidant activity and growth inhibition of human tumour cell lines. Food and Chemical Toxicology 2010, 48:2881-2884.
29. Zaidman B.-Z., Yassin M., Mahajna J., Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Applied Microbiology and Biotechnology 2005, 67:453-468.